Company: HROW
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001641172-25-014234
Chunk: 0

Company: HARROW, INC.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Items.

On
June 9, 2025, Harrow, Inc. announced that it and a wholly-owned subsidiary (together, the “ Company”) had entered into a license
and supply agreement (the “ Agreement”) with Formosa Pharmaceuticals, Inc. (“ Formosa”). Under the terms of the
Agreement, the Company licensed from Formosa the exclusive rights and marketing authorization of BYQLOVI TM consideration for such rights, the Company
will make a one-time payment to will be eligible to receive other one-time
payments based on achievement of commercial gross profit milestones along with royalties on gross profits of BYQLOVI.

A
copy of the press release announcing the Agreement is filed as Exhibit 99

Item
9.01 Financial Statements and Exhibits.